|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for SLC19A1 |
Top |
Phenotypic Information for SLC19A1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: SLC19A1 |
Familial Cancer Database: SLC19A1 |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS |
Mutations for SLC19A1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows SLC19A1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
There's no copy number variation information in COSMIC data for this gene. |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=30) | (# total SNVs=12) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr21:46951556-46951556 | p.P232P | 5 |
chr21:46957794-46957794 | p.H27R | 4 |
chr21:46950811-46950811 | p.V342I | 2 |
chr21:46935678-46935678 | p.E557V | 1 |
chr21:46951464-46951464 | p.R263Q | 1 |
chr21:46945798-46945798 | p.I409T | 1 |
chr21:46951714-46951714 | p.V180F | 1 |
chr21:46951334-46951334 | p.N306N | 1 |
chr21:46951972-46951972 | p.P94S | 1 |
chr21:46935724-46935724 | p.T542A | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 3 | 1 |   | 5 | 1 |   | 4 |   | 2 |   |   | 2 |   |   |   |   | 6 | 3 |   | 11 |
# mutation | 3 | 1 |   | 6 | 1 |   | 5 |   | 2 |   |   | 2 |   |   |   |   | 6 | 4 |   | 12 |
nonsynonymous SNV | 2 | 1 |   | 6 | 1 |   | 1 |   | 1 |   |   | 1 |   |   |   |   | 4 | 3 |   | 9 |
synonymous SNV | 1 |   |   |   |   |   | 4 |   | 1 |   |   | 1 |   |   |   |   | 2 | 1 |   | 3 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr21:46951414 | p.G240S,SLC19A1 | 2 |
chr21:46935726 | p.V446L,SLC19A1 | 1 |
chr21:46951701 | p.A262V,SLC19A1 | 1 |
chr21:46950869 | p.A113A,SLC19A1 | 1 |
chr21:46957703 | p.A441V,SLC19A1 | 1 |
chr21:46951450 | p.Y247Y,SLC19A1 | 1 |
chr21:46935892 | p.R108C,SLC19A1 | 1 |
chr21:46951793 | p.S396F,SLC19A1 | 1 |
chr21:46950872 | p.V104M,SLC19A1 | 1 |
chr21:46951483 | p.V381V,SLC19A1 | 1 |
Other DBs for Point Mutations |
Copy Number for SLC19A1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for SLC19A1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
BOP1,C20orf27,C21orf33,FAM207A,DAZAP1,EXOSC4,FBXL6, SLC52A2,TONSL,PFKL,PRR7,PUF60,PWP2,RECQL4, RRP1,RRP9,SLC19A1,TIGD5,U2AF1,VARS,WDR4 | ACY1,BCAP31,BOK,DGAT1,IMPDH1,KLHL22,LPHN1, LRP3,PDXK,PIGS,PLEKHG6,POLR2E,POR,SCRN2, SLC19A1,SLC25A10,TALDO1,TMEM53,TST,TUBG1,TYSND1 | ||||
ATAD3A,FAM207A,HGH1,DAZAP1,DDX51,DOHH,LONP1, NCLN,TONSL,NOC4L,PUS1,PWP2,RRP12,RRP1, RRP1B,SLC19A1,SRM,TMEM201,TRAP1,U2AF1,WDR4 | ABHD15,ACAD10,ACADS,ACO2,ACSF3,ADH6,AFG3L2, FAM213B,SLC52A3,CEBPA,CLPTM1,CMBL,DQX1,EPHA1, GJB1,KBTBD11,PAQR5,PFKL,SLC19A1,SPNS1,TMEM19 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for SLC19A1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB01234 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Dexamethasone | ||
DB00515 | solute carrier family 19 (folate transporter), member 1 | approved | Cisplatin | ||
DB00531 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Cyclophosphamide | ||
DB00970 | solute carrier family 19 (folate transporter), member 1 | approved | Dactinomycin | ||
DB00997 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Doxorubicin | ||
DB01611 | solute carrier family 19 (folate transporter), member 1 | approved | Hydroxychloroquine | ||
DB00795 | solute carrier family 19 (folate transporter), member 1 | approved | Sulfasalazine | ||
DB00145 | solute carrier family 19 (folate transporter), member 1 | approved; nutraceutical | Glycine | ||
DB00133 | solute carrier family 19 (folate transporter), member 1 | approved; nutraceutical | L-Serine | ||
DB00293 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Raltitrexed | ||
DB00158 | solute carrier family 19 (folate transporter), member 1 | approved; nutraceutical | Folic Acid | ||
DB00987 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Cytarabine | ||
DB00694 | solute carrier family 19 (folate transporter), member 1 | approved | Daunorubicin | ||
DB00773 | solute carrier family 19 (folate transporter), member 1 | approved | Etoposide | ||
DB00650 | solute carrier family 19 (folate transporter), member 1 | approved | Leucovorin | ||
DB01033 | solute carrier family 19 (folate transporter), member 1 | approved | Mercaptopurine | ||
DB00563 | solute carrier family 19 (folate transporter), member 1 | approved | Methotrexate | ||
DB00635 | solute carrier family 19 (folate transporter), member 1 | approved | Prednisone | ||
DB00541 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Vincristine | ||
DB00544 | solute carrier family 19 (folate transporter), member 1 | approved | Fluorouracil | ||
DB00762 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Irinotecan | ||
DB00958 | solute carrier family 19 (folate transporter), member 1 | approved | Carboplatin | ||
DB00642 | solute carrier family 19 (folate transporter), member 1 | approved; investigational | Pemetrexed |
Top |
Cross referenced IDs for SLC19A1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |